Laurus Labs Profit & Loss Annual

Trade
BSE: 540222 | NSE: LAURUSLABS | ISIN: INE947Q01028 | Sector: Biotechnology & Drugs
455.95 +2.55 (0.56%)Updated : 22 May 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 5,040.836,040.554,935.574,813.51
Total Revenue 5,040.836,040.554,935.574,813.51
Costof Revenue Total 2,432.423,164.812,452.792,355.12
Gross Profit 2,608.412,875.742,482.782,458.39
Selling/ General/ Admin Expenses Total 639.931,257.291,057.24906.76
Depreciation/ Amortization 384.58324.08251.49205.07
Other Operating Expenses Total 1,190.980.73-0.52-3.79
Total Operating Expense 4,647.914,746.913,761.003,463.16
Operating Income 392.921,293.641,174.571,350.35
Interest Inc( Exp) Net- Non- Op Total -1,829.00-1,658.30-740.20-388.80
Other Net 26.34-18.66-15.49-9.75
Net Income Before Taxes 236.361,108.941,083.851,301.11
Provisionfor Income Taxes 68.15312.30251.42317.29
Net Income After Taxes 168.21796.64832.43983.82
Minority Interest -1.72-3.32-4.71-0.24
Equity In Affiliates -59.40-32.10-2.00-
Net Income Before Extra Items 160.55790.11827.52983.58
Net Income 160.55790.11827.52983.58
Income Availableto Com Excl Extra Ord 160.55790.11827.52983.58
Income Availableto Com Incl Extra Ord 160.55790.11827.52983.58
Diluted Net Income 160.55790.11827.52983.58
Diluted Weighted Average Shares 54.0653.9653.9253.81
Diluted EPS Excluding Extra Ord Items 2.9714.6415.3518.28
DPS- Common Stock Primary Issue 0.801.20--
Diluted Normalized EPS 2.9714.6515.3718.29
Gain( Loss)on Saleof Assets --2.10-12.10-6.10
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,361.00+50.75(2.20%)
2,919.65+48.35(1.68%)
9,911.05+112.45(1.15%)
HomeMarketsPremiumFor youGet App